Brazil Healthcare - New Opportunities for Growth
Brazil is considered as one of the most lucrative healthcare market in Latin America with highest healthcare expenditure. Strong government support and high healthcare services demand are some of the major factors propelling the country’s healthcare market to grow at a fast pace. The Brazilian Government has adopted several initiatives and implemented proper plans and policies that resulted in positive development of the overall healthcare services and facilities.
According to our report, “Brazil Healthcare - New Opportunities for Growth”, the healthcare expenditure in the country has been rising continuously with better standards of living. Healthcare spending in the country is also anticipated to grow at a CAGR of around 8.6% during 2012-2015. The main factors behind the high healthcare expenditure include the prevalence of various diseases in the country. Almost one-fourth of the population is suffering from hypertension. Other major prevalent diseases covered in the report include cancer, tuberculosis, obesity, and diabetes.
Among the healthcare sectors, the pharmaceutical market in the country witnessed tremendous growth, especially generics market that witnessed more than 40% growth in 2011 against the previous year. With several factors, such as increasing patent expiries and greater generic company involvement in Brazil, the segment is anticipated to be the main factor for growth of the pharmaceutical market in the country. Besides, innovation and improvements in the medical equipment sector have been consistent in Brazil.
Besides, as per our findings, the future outlook of Brazil healthcare IT-industry is quite optimistic as hospitals in the country are investing huge amounts of money in information technology. The world’s leading healthcare IT-companies are also looking towards Brazil as an ideal destination for their business expansion. For instance, Agfa HealthCare has acquired the Brazil’s healthcare IT-company and also into partnership with hospitals to provide IT-solutions in the country. In such a scenario, the sector offers significant attraction to several stakeholders, and those participating in the industry developments.
Besides, private healthcare insurance industry is growing in the country as large percentage of population is covered under Unified Health System. However, people are moving towards private healthcare plans and the number of people covered under private healthcare plans has increased to almost one-third of the total population. In addition, the report covers the detail analysis of medical tourism industry, clinical trials and biotech industry in Brazil.
The report “Brazil Healthcare - New Opportunities for Growth” covers all the necessary aspects of the Brazilian healthcare market, providing an in-depth research and prudent analysis of the key segments. The segments covered in the report include: Hospital Services Industry, Pharmaceutical Industry, Medical Devices Industry, Healthcare IT industry and other emerging market segments. It also presents an insight into the current industry trends; key market drivers, and the government initiatives to enable the clients understand the market structure and it’s prospective during the forecast period. The report also covers detailed information about the active market players in hospital services, pharmaceutical, medical devices and healthcare IT-sector.
According to our report, “Brazil Healthcare - New Opportunities for Growth”, the healthcare expenditure in the country has been rising continuously with better standards of living. Healthcare spending in the country is also anticipated to grow at a CAGR of around 8.6% during 2012-2015. The main factors behind the high healthcare expenditure include the prevalence of various diseases in the country. Almost one-fourth of the population is suffering from hypertension. Other major prevalent diseases covered in the report include cancer, tuberculosis, obesity, and diabetes.
Among the healthcare sectors, the pharmaceutical market in the country witnessed tremendous growth, especially generics market that witnessed more than 40% growth in 2011 against the previous year. With several factors, such as increasing patent expiries and greater generic company involvement in Brazil, the segment is anticipated to be the main factor for growth of the pharmaceutical market in the country. Besides, innovation and improvements in the medical equipment sector have been consistent in Brazil.
Besides, as per our findings, the future outlook of Brazil healthcare IT-industry is quite optimistic as hospitals in the country are investing huge amounts of money in information technology. The world’s leading healthcare IT-companies are also looking towards Brazil as an ideal destination for their business expansion. For instance, Agfa HealthCare has acquired the Brazil’s healthcare IT-company and also into partnership with hospitals to provide IT-solutions in the country. In such a scenario, the sector offers significant attraction to several stakeholders, and those participating in the industry developments.
Besides, private healthcare insurance industry is growing in the country as large percentage of population is covered under Unified Health System. However, people are moving towards private healthcare plans and the number of people covered under private healthcare plans has increased to almost one-third of the total population. In addition, the report covers the detail analysis of medical tourism industry, clinical trials and biotech industry in Brazil.
The report “Brazil Healthcare - New Opportunities for Growth” covers all the necessary aspects of the Brazilian healthcare market, providing an in-depth research and prudent analysis of the key segments. The segments covered in the report include: Hospital Services Industry, Pharmaceutical Industry, Medical Devices Industry, Healthcare IT industry and other emerging market segments. It also presents an insight into the current industry trends; key market drivers, and the government initiatives to enable the clients understand the market structure and it’s prospective during the forecast period. The report also covers detailed information about the active market players in hospital services, pharmaceutical, medical devices and healthcare IT-sector.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. HEALTHCARE MARKET OVERVIEW
4. MARKET TRENDS & DRIVERS
4.1 Favorable Demographics
4.2 Epidemiology
4.2.1 Tuberculosis
4.2.2 Hypertension
4.2.3 Obesity
4.2.4 Diabetes
4.2.5 Cancer
4.3 Government Support to Boost Healthcare Sector
4.4 Growing Healthcare Infrastructure and R&D Investments
5. HEALTHCARE INDUSTRY OUTLOOK
5.1 Healthcare Infrastructure
5.1.1 Hospitals
5.1.2 Beds
5.1.3 Human Resource
5.2 Pharmaceutical Market
5.2.1 Generic Drugs
5.2.2 OTC Drugs
5.2.3 Import and Export
5.2.4 Mergers & Acquisitions
5.3 Medical Equipment Industry
5.4 Healthcare IT Market
5.4.1 E-health
5.4.2 M-health
5.4.3 Telemedicine
5.4.4 Medical Imaging Information System
6. MARKET OPPORTUNITIES
6.1 Health Insurance Industry
6.2 Medical Tourism Industry
6.3 Clinical Trials Industry
6.4 Biotech Industry
7. REGULATORY ENVIRONMENT
8. GOVERNMENT HEALTHCARE PROGRAMS
9. COMPETITIVE LANDSCAPE
9.1 Hospital Services
9.1.1 Group Hospital Conceição (GHC)
9.1.2 Rede D'Or Ltda.
9.1.3 The Albert Einstein Israeli Hospital (HIAE)
9.1.4 Universidade Federal do Maranhão (UFMA)
9.2 Pharmaceuticals
9.2.1 Sanofi-Aventis
9.2.2 Bayer
9.2.3 Novartis
9.2.4 Pfizer
9.3 Medical Equipment
9.3.1 3M
9.3.2 Air Liquide
9.3.3 Baxter
9.4 Healthcare IT
9.4.1 Agfa HealthCare
9.4.2 MV Sistemas
9.4.3 Wheb Sistemas SA
9.4.4 TOTVS
2. RESEARCH METHODOLOGY
3. HEALTHCARE MARKET OVERVIEW
4. MARKET TRENDS & DRIVERS
4.1 Favorable Demographics
4.2 Epidemiology
4.2.1 Tuberculosis
4.2.2 Hypertension
4.2.3 Obesity
4.2.4 Diabetes
4.2.5 Cancer
4.3 Government Support to Boost Healthcare Sector
4.4 Growing Healthcare Infrastructure and R&D Investments
5. HEALTHCARE INDUSTRY OUTLOOK
5.1 Healthcare Infrastructure
5.1.1 Hospitals
5.1.2 Beds
5.1.3 Human Resource
5.2 Pharmaceutical Market
5.2.1 Generic Drugs
5.2.2 OTC Drugs
5.2.3 Import and Export
5.2.4 Mergers & Acquisitions
5.3 Medical Equipment Industry
5.4 Healthcare IT Market
5.4.1 E-health
5.4.2 M-health
5.4.3 Telemedicine
5.4.4 Medical Imaging Information System
6. MARKET OPPORTUNITIES
6.1 Health Insurance Industry
6.2 Medical Tourism Industry
6.3 Clinical Trials Industry
6.4 Biotech Industry
7. REGULATORY ENVIRONMENT
8. GOVERNMENT HEALTHCARE PROGRAMS
9. COMPETITIVE LANDSCAPE
9.1 Hospital Services
9.1.1 Group Hospital Conceição (GHC)
9.1.2 Rede D'Or Ltda.
9.1.3 The Albert Einstein Israeli Hospital (HIAE)
9.1.4 Universidade Federal do Maranhão (UFMA)
9.2 Pharmaceuticals
9.2.1 Sanofi-Aventis
9.2.2 Bayer
9.2.3 Novartis
9.2.4 Pfizer
9.3 Medical Equipment
9.3.1 3M
9.3.2 Air Liquide
9.3.3 Baxter
9.4 Healthcare IT
9.4.1 Agfa HealthCare
9.4.2 MV Sistemas
9.4.3 Wheb Sistemas SA
9.4.4 TOTVS
LIST OF FIGURES
Figure 3-1: Healthcare Expenditure (Billion US$), 2010-2015
Figure 3-2: Healthcare Spending Percentage of GDP in Comparison to Latin American Countries (2010)
Figure 4-1: Spending on Medicines by Age Group (%)
Figure 4-2: Percentage of Key Diseases in Total Population (2011)
Figure 4-3: Percentage of Population Diagnosed with Hypertension (2006, 2011 & 2015)
Figure 4-4: Prevalence of Hypertension by Age Group (%), 2011
Figure 4-5: Percentage of Population with Obesity (2006, 2011 & 2015)
Figure 4-6: Percentage of Population with Diabetes (2006, 2011 & 2015)
Figure 5-1: Share of Public and Private Hospitals (2011)
Figure 5-2: Forecast for Share of Public and Private Hospitals (2015)
Figure 5-3: Number of Hospital Beds ('000), 2010-2015
Figure 5-4: Share of Public and Private Hospital Beds (2011)
Figure 5-5: Number of Doctors (‘000), 2010-2015
Figure 5-6: Number of Nurses (‘000), 2010-2015
Figure 5-7: Share of Brazilian Pharmaceutical Market in Latin America (2011)
Figure 5-8: Pharmaceutical Market (Billion BRL), 2010-2015
Figure 5-9: Pharmaceutical Market (Billion Units), 2009-2012
Figure 5-10: Pharmaceutical Market by Segment (%), 2011
Figure 5-11: Forecast for Pharmaceutical Market by Segment (%), 2015
Figure 5-12: Share of Domestic and Foreign Pharmaceutical Laboratories (2006-2012)
Figure 5-13: Pharmaceutical Market by Region (%), 2011
Figure 5-14: Generic Drugs Market (Billion BRL), 2010-2015
Figure 5-15: Generic Drugs Market (Million Units), 2009-2011
Figure 5-16: OTC Drug Market (Billion US$), 2010-2015
Figure 5-17: Pharmaceutical Imports (Billion US$), 2008-2010
Figure 5-18: Pharmaceutical Exports (Billion US$), 2008-2010
Figure 5-19: Medical Equipment Market (Billion US$), 2010-2015
Figure 5-20: Medical Equipment Imports (Billion US$), 2009-2011
Figure 5-21: Medical Equipment Exports (Million US$), 2009-2011
Figure 5-22: Healthcare IT Market (Billion US$), 2010-2015
Figure 5-23: E-health Market (Million US$), 2010-2015
Figure 5-24: M-health Market (Million US$), 2010-2015
Figure 5-25: Telemedicine Market (Million US$), 2010-2015
Figure 5-26: Medical Imaging Information System Market (Million US$), 2010-2015
Figure 5-27: Picture Archiving and Communications Systems (PACS) Market (Million US$), 2009-2015
Figure 6-1: Private Health Insurance Net Premium (Billion BRL), 2008-2011
Figure 6-2: Number of Clinical Studies (2008-2011)
Figure 3-1: Healthcare Expenditure (Billion US$), 2010-2015
Figure 3-2: Healthcare Spending Percentage of GDP in Comparison to Latin American Countries (2010)
Figure 4-1: Spending on Medicines by Age Group (%)
Figure 4-2: Percentage of Key Diseases in Total Population (2011)
Figure 4-3: Percentage of Population Diagnosed with Hypertension (2006, 2011 & 2015)
Figure 4-4: Prevalence of Hypertension by Age Group (%), 2011
Figure 4-5: Percentage of Population with Obesity (2006, 2011 & 2015)
Figure 4-6: Percentage of Population with Diabetes (2006, 2011 & 2015)
Figure 5-1: Share of Public and Private Hospitals (2011)
Figure 5-2: Forecast for Share of Public and Private Hospitals (2015)
Figure 5-3: Number of Hospital Beds ('000), 2010-2015
Figure 5-4: Share of Public and Private Hospital Beds (2011)
Figure 5-5: Number of Doctors (‘000), 2010-2015
Figure 5-6: Number of Nurses (‘000), 2010-2015
Figure 5-7: Share of Brazilian Pharmaceutical Market in Latin America (2011)
Figure 5-8: Pharmaceutical Market (Billion BRL), 2010-2015
Figure 5-9: Pharmaceutical Market (Billion Units), 2009-2012
Figure 5-10: Pharmaceutical Market by Segment (%), 2011
Figure 5-11: Forecast for Pharmaceutical Market by Segment (%), 2015
Figure 5-12: Share of Domestic and Foreign Pharmaceutical Laboratories (2006-2012)
Figure 5-13: Pharmaceutical Market by Region (%), 2011
Figure 5-14: Generic Drugs Market (Billion BRL), 2010-2015
Figure 5-15: Generic Drugs Market (Million Units), 2009-2011
Figure 5-16: OTC Drug Market (Billion US$), 2010-2015
Figure 5-17: Pharmaceutical Imports (Billion US$), 2008-2010
Figure 5-18: Pharmaceutical Exports (Billion US$), 2008-2010
Figure 5-19: Medical Equipment Market (Billion US$), 2010-2015
Figure 5-20: Medical Equipment Imports (Billion US$), 2009-2011
Figure 5-21: Medical Equipment Exports (Million US$), 2009-2011
Figure 5-22: Healthcare IT Market (Billion US$), 2010-2015
Figure 5-23: E-health Market (Million US$), 2010-2015
Figure 5-24: M-health Market (Million US$), 2010-2015
Figure 5-25: Telemedicine Market (Million US$), 2010-2015
Figure 5-26: Medical Imaging Information System Market (Million US$), 2010-2015
Figure 5-27: Picture Archiving and Communications Systems (PACS) Market (Million US$), 2009-2015
Figure 6-1: Private Health Insurance Net Premium (Billion BRL), 2008-2011
Figure 6-2: Number of Clinical Studies (2008-2011)
LIST OF TABLES
Table 4-1: Demographic Characteristics (2010-2015)
Table 4-2: Breakup of Obese People by Age Group (%)
Table 4-3: Overweight Population by Gender (%), 2011 & 2015
Table 5-1: Number of Healthcare Institutions (2011)
Table 5-2: Number of Public Hospital Network Working for SUS (2010)
Table 5-3: Healthcare Human Resources Statistics (2009-10)
Table 5-4: Number of Doctors per Thousand Population By Top Cities (2010)
Table 5-5: Market Share of Leading Pharmaceutical Companies (2011)
Table 5-6: Leading Drugs by Sales (Million US$)
Table 5-7: Market Share of Leading Generic Drugs Companies (2010)
Table 5-8: Pharma-related Mergers and Acquisitions (2010-2012)
Table 8-1: Key Goals under Various Parts of UPA 24-hours Program
Table 4-1: Demographic Characteristics (2010-2015)
Table 4-2: Breakup of Obese People by Age Group (%)
Table 4-3: Overweight Population by Gender (%), 2011 & 2015
Table 5-1: Number of Healthcare Institutions (2011)
Table 5-2: Number of Public Hospital Network Working for SUS (2010)
Table 5-3: Healthcare Human Resources Statistics (2009-10)
Table 5-4: Number of Doctors per Thousand Population By Top Cities (2010)
Table 5-5: Market Share of Leading Pharmaceutical Companies (2011)
Table 5-6: Leading Drugs by Sales (Million US$)
Table 5-7: Market Share of Leading Generic Drugs Companies (2010)
Table 5-8: Pharma-related Mergers and Acquisitions (2010-2012)
Table 8-1: Key Goals under Various Parts of UPA 24-hours Program
